Filing Details

Accession Number:
0001127602-18-018535
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-23 15:16:04
Reporting Period:
2018-05-21
Accepted Time:
2018-05-23 15:16:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1705843 Calyxt Inc. CLXT Agricultural Chemicals (2870) 271967997
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1712191 F Daniel Voytas 600 County Road D West
Suite 8
New Brighton MN 55112
Chief Science Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-21 4,666 $3.59 105,187 No 4 M Direct
Common Stock Disposition 2018-05-21 4,666 $16.63 100,521 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-05-21 4,666 $0.00 4,666 $3.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
231,002 2026-04-07 No 4 M Direct
Footnotes
  1. Includes 100,521 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and vest 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.
  3. The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50-$16.76, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. The Stock Option was granted on April 7, 2016 and vests 20% on the grant date and 10% on the first anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter).